Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects

IL-10: The Master Regulator of Immunity to Infection

(2014) Kevin N. Couper et al.   JOURNAL OF IMMUNOLOGY

Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease

(2014) Dimitris Tousoulis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lovastatin-induced decrease of intracellular cholesterol level attenuates fibroblast-to-myofibroblast transition in bronchial fibroblasts derived from asthmatic patients

(2013) Marta Michalik et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Genotype-Dependent Effects of TGF- 1 on Mast Cell Function: Targeting the Stat5 Pathway

(2013) J. Fernando et al.   JOURNAL OF IMMUNOLOGY

Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma

(2012) Lan Xu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Lyn but Not Fyn Kinase Controls IgG-Mediated Systemic Anaphylaxis

(2012) Y. T. Falanga et al.   JOURNAL OF IMMUNOLOGY

Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis

(2012) Tasneem Lokhandwala et al.   BMJ Open

Endogenous suppression of mast cell development and survival by IL-4 and IL-10

(2009) Kelly Speiran et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level

(2008) Masanori Fujimoto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma

(2008) E J Hothersall et al.   THORAX